Nationwide Implementation of Nonpharmaceutical Interventions During the Coronavirus Disease 2019 Pandemic Is Associated With Decreased Incidence of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients
- PMID: 35770128
- PMCID: PMC9223043
- DOI: 10.1093/ofid/ofac076
Nationwide Implementation of Nonpharmaceutical Interventions During the Coronavirus Disease 2019 Pandemic Is Associated With Decreased Incidence of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients
Abstract
This study aimed to investigate the impact of nationwide nonpharmaceutical interventions against coronavirus disease 2019 (COVID-19) on the incidence of Pneumocystis jirovecii pneumonia (PCP) in kidney transplant recipients. The monthly incidence of PCP during the COVID-19 period decreased significantly compared to that of the pre-COVID-19 period in kidney transplant recipients.
Keywords: COVID-19; Pneumocystis jirovecii pneumonia; kidney transplant recipients; nonpharmaceutical interventions.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures
References
-
- Neff RT, Jindal RM, Yoo DY, Hurst FP, Agodoa LY, Abbott KC.. Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia. Transplantation 2009; 88:135–41. - PubMed
-
- World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19, 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-genera.... Accessed 27 September 2021.
-
- Abbas S, Raybould JE, Sastry S, de la Cruz O.. Respiratory viruses in transplant recipients: more than just a cold. Clinical syndromes and infection prevention principles. Int J Infect Dis 2017; 62:86–93. - PubMed
LinkOut - more resources
Full Text Sources